ID: hsa-mir-3685
chr12:95703649-95703810 +
Display Libraries
(1)
AGO1.ip
(1)
AGO1.ip OTHER.mut
(2)
AGO2.ip
(3)
B-CELL
(5)
BRAIN
(4)
BREAST
(28)
CELL-LINE
(1)
CERVIX
(1)
FIBROBLAST
(5)
HEART
(3)
HELA
(1)
LIVER
(1)
OTHER
(14)
SKIN
(1)
XRN.ip
Showing top 33 reads
GGTATTTTCATTTTTACTTTTTGATTAATTGTGTTTTATATATTAGGGTAGTACATTTCCTACCCTACCTGAAGACTTGAGATTATAGTCTTTGGGGGGATGGGCAAAGTACTCTCTTTTTTTGCATCTTTTAAATTGTGATTTTTAAAAACACATATAAAT
..................................................((((.((.(((((((..((..((((((.........))))))..))))).)))).)).))))..................................................
..................................................51...........................................................112................................................
SizePerfect hitTotal NormPerfect NormSRR037941(GSM510479)
293DroshaTN. (cell line)
SRR207113(GSM721075)
IP against AGO 1 & 2. (ago1/2 cell line)
SRR387910(GSM843862)
antibody for ip: Ago2. (ago2 cell line)
SRR037944(GSM510482)
293DcrTN_cand5. (cell line)
SRR037937(GSM510475)
293cand2. (cell line)
SRR314796(SRX084354)
Total RNA, fractionated (15-30nt). (cell line)
SRR033722(GSM497067)
KMS12 cell line (KMS12). (B cell)
SRR189787SRR189782SRR189779(GSM714639)
cell line: HEK293clip variant: PAR-CLIPenzyma. (cell line)
SRR189780(GSM714640)
cell line: HEK293clip variant: PAR-CLIPenzyma. (cell line)
SRR037938(GSM510476)
293Red. (cell line)
SRR207111(GSM721073)
Whole cell RNA. (cell line)
SRR444059(SRX128907)
Sample 17cDNABarcode: AF-PP-339: ACG CTC TTC . (skin)
SRR189786SRR342897(SRX096793)
small RNA seq of Left atrial tissue. (heart)
SRR342896(SRX096792)
small RNA seq of Right atrial tissue. (heart)
SRR189778(GSM714638)
cell line: HEK293clip variant: PAR-CLIPenzyma. (cell line)
SRR189781(GSM714641)
cell line: HEK293clip variant: PAR-CLIPenzyma. (cell line)
DRR001489(DRX001043)
Hela short nuclear cell fraction, control. (hela)
RoviraIPAgo2(Rovira)
total RNA. (ago2 breast)
SRR342899(SRX096795)
small RNA seq of Left atrial tissue. (heart)
SRR330889(SRX091727)
tissue: skin psoriatic uninvolveddisease stat. (skin)
DRR001488(DRX001042)
Hela short nuclear cell fraction, LNA(+). (hela)
SRR189784SRR029124(GSM416753)
HeLa. (hela)
SRR039191(GSM494810)
PBMCs were isolated by ficoll gradient from t. (blood)
SRR330879(SRX091717)
tissue: skin psoriatic involveddisease state:. (skin)
SRR330881(SRX091719)
tissue: skin psoriatic uninvolveddisease stat. (skin)
SRR330888(SRX091726)
tissue: skin psoriatic uninvolveddisease stat. (skin)
GSM450607(GSM450607)
miRNA sequencing raw reads from post-mortem s. (brain)
GSM450601(GSM450601)
miRNA sequencing raw reads from post-mortem s. (brain)
SRR343332(GSM796035)
KSHV (HHV8), EBV (HHV-4). (cell line)
SRR326279(GSM769509)
cytoplasmic fraction was isolated using PARIS. (cell line)
SRR330885(SRX091723)
tissue: skin psoriatic uninvolveddisease stat. (skin)
SRR037943(GSM510481)
293DcrTN. (cell line)
SRR139170(SRX050649)
FLASHPage purified small RNA (~15-40nt) from . (heart)
GSM416733(GSM416733)
HEK293. (cell line)
SRR191621(GSM715731)
16genomic small RNA (size selected RNA from t. (breast)
SRR330904(SRX091742)
tissue: normal skindisease state: normal. (skin)
SRR038855(GSM458538)
D10. (cell line)
SRR039192(GSM494811)
K562 cell line is derived from a CML patient . (cell line)
SRR037931(GSM510469)
293GFP. (cell line)
SRR060982(GSM569186)
Human centrocyte [09-001]. (cell line)
SRR040007(GSM532892)
G601T. (cervix)
SRR207114(GSM721076)
IP against AGO 1 & 2, RRP40 knockdown. (ago1/2 RRP40 cell line)
SRR330899(SRX091737)
tissue: skin psoriatic uninvolveddisease stat. (skin)
SRR330861(SRX091699)
tissue: skin psoriatic involveddisease state:. (skin)
SRR039193(GSM494812)
HL60 cell line is derived from acute promyelo. (cell line)
SRR029126(GSM416755)
143B. (cell line)
SRR207115(GSM721077)
XRN1&2 knockdown. (XRN1/XRN2 cell line)
SRR330868(SRX091706)
tissue: skin psoriatic involveddisease state:. (skin)
SRR342900(SRX096796)
small RNA seq of Right atrial tissue. (heart)
GSM450608(GSM450608)
miRNA sequencing raw reads from post-mortem s. (brain)
SRR330902(SRX091740)
tissue: skin psoriatic uninvolveddisease stat. (skin)
SRR326282(GSM769512)
Dicer mRNA was knocked down using siDicer, to. (cell line)
GSM450599(GSM450599)
miRNA sequencing raw reads from post-mortem s. (brain)
SRR033730(GSM497075)
Lymphoblastic (ALL411). (B cell)
SRR033714(GSM497059)
Burkitt Lymphoma (BL134). (B cell)
TAX577738(Rovira)
total RNA. (breast)
SRR326280(GSM769510)
total cell content of unperturbed cells was s. (cell line)
GSM450597(GSM450597)
miRNA sequencing raw reads from post-mortem s. (brain)
SRR330878(SRX091716)
tissue: skin psoriatic involveddisease state:. (skin)
SRR363674(GSM830251)
cell type: human foreskin fibroblasts (HFF)tr. (fibroblast)
SRR330876(SRX091714)
tissue: skin psoriatic involveddisease state:. (skin)
TAX577745(Rovira)
total RNA. (breast)
SRR037933(GSM510471)
293cand4_rep2. (cell line)
SRR060981(GSM569185)
Human centroblast [09-001]. (cell line)
SRR039611(GSM531974)
Human Normal Liver Tissue Sample 1. (liver)
SRR330894(SRX091732)
tissue: skin psoriatic uninvolveddisease stat. (skin)
.......................................................TTTCCTACCCTACCTGAAGACT.....................................................................................22167.0067.0016.007.0010.001.003.00-2.00-1.00--2.00----2.00--1.00--1.00----1.001.001.001.00---1.00--1.00--1.00-1.00--1.00-1.001.00-1.001.001.001.00-1.00---1.00-1.001.00-1.001.00----
........................................................TTCCTACCCTACCTGAAGACT.....................................................................................21116.0016.003.00--3.003.00------1.00---1.00----------------1.00-----1.00-------1.00-------------1.00------1.00--
......................................................ATTTCCTACCCTACCTGAAGACT.....................................................................................23115.0015.00-2.00-2.00---1.00------1.001.00-------1.00--1.00------1.00-1.00---1.00---1.00----------------------1.00-1.00-
.......................................................TTTCCTACCCTACCTGAAGACTatc..................................................................................25ATC5.0067.00-----5.00----------------------------------------------------------------
......................................................ATTTCCTACCCTACCTGAAGAC......................................................................................2213.003.00------1.00-------1.00-------------------------------------------1.00-----------
........................................................................................................CAAAGTACTCTCTTTTTg........................................18G3.000.00--------2.00---------------1.00---------------------------------------------
........................................................TTCCTACCCTACCTGAAGA.......................................................................................1913.003.00---3.00------------------------------------------------------------------
.....TTTCATTTTTACTTTTTattg........................................................................................................................................21ATTG2.000.00-----------------2.00----------------------------------------------------
.......................................................TTTCCTACCCTACCTGAAG........................................................................................1912.002.00------------2.00---------------------------------------------------------
............................................................................................TGGGGGGATGGGCAAAGTACTCTCTTTTTgc.......................................31GC2.000.00---------2.00------------------------------------------------------------
.......................................................TTTCCTACCCTACCTGAAGA.......................................................................................2012.002.00-------------------------1.00-----------------------1.00--------------------
......................................................ATTTCCTACCCTACCTGAAGACc.....................................................................................23C1.003.00-------1.00--------------------------------------------------------------
.......................................................TTTCCTACCCTACCTGAcgcc......................................................................................21CGCC1.000.00--------------------------------------------1.00-------------------------
...........................................................................................TTGGGGGGATGGGCAAAGTACTCTg..............................................25G1.000.00------------------------------------------------------1.00---------------
.............................................................................TGAGATTATAGTCTTTGGGGGGATGGGCAAAGTACT.................................................3611.001.00--------------------1.00-------------------------------------------------
......................................................ATTTCCTACCCTACCTGAAGAtt.....................................................................................23TT1.000.00-1.00--------------------------------------------------------------------
.....................................................................................TAGTCTTTGGGGGGATGGGCAAAG.....................................................2411.001.00----------1.00-----------------------------------------------------------
......................................................ATTTCCTACCCTACCTGAAGACa.....................................................................................23A1.003.00---------------------------------------------------------------1.00------
...ATTTTCATTTTTACTTTattt..........................................................................................................................................21ATTT1.000.00------------------1.00---------------------------------------------------
..............................................................................................GGGGGATGGGCAAAGTACTCTCTTTTTgc.......................................29GC1.000.00----------1.00-----------------------------------------------------------
........................................................TTCCTACCCTACCTGAAGACTT....................................................................................2211.001.00---------------------1.00------------------------------------------------
..........................................................................................TTTGGGGGGATGGGCAAAGTAa..................................................22A1.000.00---------------------------------------------------------1.00------------
.......................................................TTTCCTACCCTACCTGAAGACc.....................................................................................22C1.000.001.00---------------------------------------------------------------------
...ATTTTCATTTTTACTctct............................................................................................................................................19CTCT1.000.00---------1.00------------------------------------------------------------
.....................................................................................................................TTTTTTGCATCTTTTggta..........................19GGTA1.000.00------------------1.00---------------------------------------------------
...........................................................CTACCCTACCTGAAGACTTGAGATTA.............................................................................2611.001.00-------------------------------1.00--------------------------------------
........................................................TTCCTACCCTACCTGAAGAC......................................................................................2011.001.00-------1.00--------------------------------------------------------------
.......................................................TTTCCTACCCTACCTGAAGACgag...................................................................................24GAG1.000.00----------1.00-----------------------------------------------------------
...........TTTTACTTTTTGATTAAaagg..................................................................................................................................21AAGG1.000.00------------------------------------1.00---------------------------------
......................................................ATTTCCTACCCTACCTGAAGACTa....................................................................................24A1.0015.00-----------------------------------------1.00----------------------------
..............................................................CCCTACCTGAAGACTTG...................................................................................1711.001.00--------------------------------------------------------1.00-------------
.....................................ATATATTAGGGTAGT..............................................................................................................1540.250.25---------------------------------------------------------------------0.25
.....................................................................................TAGTCTTTGGGGGGA..............................................................1560.170.17-------------------0.17--------------------------------------------------
GGTATTTTCATTTTTACTTTTTGATTAATTGTGTTTTATATATTAGGGTAGTACATTTCCTACCCTACCTGAAGACTTGAGATTATAGTCTTTGGGGGGATGGGCAAAGTACTCTCTTTTTTTGCATCTTTTAAATTGTGATTTTTAAAAACACATATAAAT
..................................................((((.((.(((((((..((..((((((.........))))))..))))).)))).)).))))..................................................
..................................................51...........................................................112................................................
SizePerfect hitTotal NormPerfect NormSRR037941(GSM510479)
293DroshaTN. (cell line)
SRR207113(GSM721075)
IP against AGO 1 & 2. (ago1/2 cell line)
SRR387910(GSM843862)
antibody for ip: Ago2. (ago2 cell line)
SRR037944(GSM510482)
293DcrTN_cand5. (cell line)
SRR037937(GSM510475)
293cand2. (cell line)
SRR314796(SRX084354)
Total RNA, fractionated (15-30nt). (cell line)
SRR033722(GSM497067)
KMS12 cell line (KMS12). (B cell)
SRR189787SRR189782SRR189779(GSM714639)
cell line: HEK293clip variant: PAR-CLIPenzyma. (cell line)
SRR189780(GSM714640)
cell line: HEK293clip variant: PAR-CLIPenzyma. (cell line)
SRR037938(GSM510476)
293Red. (cell line)
SRR207111(GSM721073)
Whole cell RNA. (cell line)
SRR444059(SRX128907)
Sample 17cDNABarcode: AF-PP-339: ACG CTC TTC . (skin)
SRR189786SRR342897(SRX096793)
small RNA seq of Left atrial tissue. (heart)
SRR342896(SRX096792)
small RNA seq of Right atrial tissue. (heart)
SRR189778(GSM714638)
cell line: HEK293clip variant: PAR-CLIPenzyma. (cell line)
SRR189781(GSM714641)
cell line: HEK293clip variant: PAR-CLIPenzyma. (cell line)
DRR001489(DRX001043)
Hela short nuclear cell fraction, control. (hela)
RoviraIPAgo2(Rovira)
total RNA. (ago2 breast)
SRR342899(SRX096795)
small RNA seq of Left atrial tissue. (heart)
SRR330889(SRX091727)
tissue: skin psoriatic uninvolveddisease stat. (skin)
DRR001488(DRX001042)
Hela short nuclear cell fraction, LNA(+). (hela)
SRR189784SRR029124(GSM416753)
HeLa. (hela)
SRR039191(GSM494810)
PBMCs were isolated by ficoll gradient from t. (blood)
SRR330879(SRX091717)
tissue: skin psoriatic involveddisease state:. (skin)
SRR330881(SRX091719)
tissue: skin psoriatic uninvolveddisease stat. (skin)
SRR330888(SRX091726)
tissue: skin psoriatic uninvolveddisease stat. (skin)
GSM450607(GSM450607)
miRNA sequencing raw reads from post-mortem s. (brain)
GSM450601(GSM450601)
miRNA sequencing raw reads from post-mortem s. (brain)
SRR343332(GSM796035)
KSHV (HHV8), EBV (HHV-4). (cell line)
SRR326279(GSM769509)
cytoplasmic fraction was isolated using PARIS. (cell line)
SRR330885(SRX091723)
tissue: skin psoriatic uninvolveddisease stat. (skin)
SRR037943(GSM510481)
293DcrTN. (cell line)
SRR139170(SRX050649)
FLASHPage purified small RNA (~15-40nt) from . (heart)
GSM416733(GSM416733)
HEK293. (cell line)
SRR191621(GSM715731)
16genomic small RNA (size selected RNA from t. (breast)
SRR330904(SRX091742)
tissue: normal skindisease state: normal. (skin)
SRR038855(GSM458538)
D10. (cell line)
SRR039192(GSM494811)
K562 cell line is derived from a CML patient . (cell line)
SRR037931(GSM510469)
293GFP. (cell line)
SRR060982(GSM569186)
Human centrocyte [09-001]. (cell line)
SRR040007(GSM532892)
G601T. (cervix)
SRR207114(GSM721076)
IP against AGO 1 & 2, RRP40 knockdown. (ago1/2 RRP40 cell line)
SRR330899(SRX091737)
tissue: skin psoriatic uninvolveddisease stat. (skin)
SRR330861(SRX091699)
tissue: skin psoriatic involveddisease state:. (skin)
SRR039193(GSM494812)
HL60 cell line is derived from acute promyelo. (cell line)
SRR029126(GSM416755)
143B. (cell line)
SRR207115(GSM721077)
XRN1&2 knockdown. (XRN1/XRN2 cell line)
SRR330868(SRX091706)
tissue: skin psoriatic involveddisease state:. (skin)
SRR342900(SRX096796)
small RNA seq of Right atrial tissue. (heart)
GSM450608(GSM450608)
miRNA sequencing raw reads from post-mortem s. (brain)
SRR330902(SRX091740)
tissue: skin psoriatic uninvolveddisease stat. (skin)
SRR326282(GSM769512)
Dicer mRNA was knocked down using siDicer, to. (cell line)
GSM450599(GSM450599)
miRNA sequencing raw reads from post-mortem s. (brain)
SRR033730(GSM497075)
Lymphoblastic (ALL411). (B cell)
SRR033714(GSM497059)
Burkitt Lymphoma (BL134). (B cell)
TAX577738(Rovira)
total RNA. (breast)
SRR326280(GSM769510)
total cell content of unperturbed cells was s. (cell line)
GSM450597(GSM450597)
miRNA sequencing raw reads from post-mortem s. (brain)
SRR330878(SRX091716)
tissue: skin psoriatic involveddisease state:. (skin)
SRR363674(GSM830251)
cell type: human foreskin fibroblasts (HFF)tr. (fibroblast)
SRR330876(SRX091714)
tissue: skin psoriatic involveddisease state:. (skin)
TAX577745(Rovira)
total RNA. (breast)
SRR037933(GSM510471)
293cand4_rep2. (cell line)
SRR060981(GSM569185)
Human centroblast [09-001]. (cell line)
SRR039611(GSM531974)
Human Normal Liver Tissue Sample 1. (liver)
SRR330894(SRX091732)
tissue: skin psoriatic uninvolveddisease stat. (skin)
................................................atggACATTTCCTACCCTA............................................................................................... 19atgg2.000.00-------------2.00--------------------------------------------------------